A 76-year-old woman presented with asymmetric chorea (Video 1) that has evolved within the past 6 weeks before admission. The cMRI showed no brain lesions apart from slight cerebral small vessel disease (Figure, A and B). The 18F-FDG-PET revealed an increased striatal metabolism (Figure, C–F) that has been reported in young patients with Sydenham chorea after Streptococcus infections.1,2 Additional laboratory tests yield an elevated anti–streptolysin O (ASO) titer with 1352 IU/mL (ref < 200 IU/mL). Suspecting a Sydenham chorea, we initiated a treatment with the antibiotic clarithromycin combined with immunomodulatory treatment (methylprednisolone and intravenous immunoglobulins) leading to significant improvement of the movement disorder (Video 1).
Video 1
Movie sequences show the patient before and after initiation of treatment.Download Supplementary Video 1 via http://dx.doi.org/10.1212/207640_Video_1
(A and B) FLAIR sequences of MRI. Apart from slight signs of cerebral small vessel disease and moderate brain atrophy, the images were unremarkable. (C–E) 18F-FDG-PET scan expressing hypermetabolism in the striatum of both hemispheres. (F and G) MRI superimposed with PET images.
New-onset Sydenham chorea rarely occurs in old age. 18F-FDG-PET can contribute to diagnosis by showing increased glucose uptake in the striatum. Affected older patients may significantly benefit from drug treatment with antibiotics and immunomodulators (additional information is listed in the Supplement [eAppendix 1, links.lww.com/WNL/D36]).
Author Contributions
A. Stuetzer: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; analysis or interpretation of data. C. Strasilla: major role in the acquisition of data; analysis or interpretation of data. F.C. Robiller: major role in the acquisition of data; analysis or interpretation of data. A. Kunze: drafting/revision of the manuscript for content, including medical writing for content; study concept or design; analysis or interpretation of data.
Study Funding
The authors report no targeted funding.
Disclosure
The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The Article Processing Charge was funded by NIH, Cleveland Clinic, Genzyme.
Submitted and externally peer reviewed. The handling editor was Editor-in-Chief José Merino, MD, MPhil, FAAN.
- Received March 13, 2023.
- Accepted in final form June 20, 2023.
- Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg